{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:50:07Z","timestamp":1781823007812,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006378","name":"Universitas Indonesia","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/501100006378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-0960-x","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T13:04:32Z","timestamp":1553087072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience"],"prefix":"10.1186","volume":"19","author":[{"given":"Yoga","family":"Fitriakusumah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-9968","authenticated-orcid":false,"given":"C. Rinaldi A.","family":"Lesmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winda Permata","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyntia O. M.","family":"Jasirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irsan","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellus","family":"Simadibrata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juferdy","family":"Kurniawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andri Sanityoso","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino A.","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"issue":"6","key":"960_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1440-1746.2007.05001.x","volume":"22","author":"S Chitturi","year":"2007","unstructured":"Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007;22(6):778\u201387.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"960_CR2","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005\u201323.","journal-title":"Hepatology."},{"issue":"1","key":"960_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/hepr.12333","volume":"45","author":"E Hashimoto","year":"2015","unstructured":"Hashimoto E, Tokushige K, Ludwig J. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: current concepts and remaining challenges. Hepatol Res. 2015;45(1):20\u20138.","journal-title":"Hepatol Res"},{"issue":"11","key":"960_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013;10(11):627\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"960_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63(3):764\u201375.","journal-title":"Hepatology."},{"issue":"2","key":"960_CR6","first-page":"112","volume":"3","author":"AC Dukowicz","year":"2007","unstructured":"Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol. 2007;3(2):112\u201322.","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"960_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1586\/17474124.2016.1110017","volume":"10","author":"FR Ponziani","year":"2016","unstructured":"Ponziani FR, Gerardi V, Gasbarrini A. Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Rev Gastroenterol Hepatol. 2016;10(2):215\u201327.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"960_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u201335.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"960_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/2050640616646528","volume":"5","author":"W-K Chan","year":"2017","unstructured":"Chan W-K, Nik Mustapha NR, Wong GL-H, Wong VW-S, Mahadeva S. Controlled attenuation parameter using the FibroScan\u00ae XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population. United European Gastroenterol J. 2017;5(1):76\u201385.","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"960_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.48.2.206","volume":"48","author":"AJ Wigg","year":"2001","unstructured":"Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2001;48(2):206\u201311.","journal-title":"Gut."},{"issue":"5","key":"960_CR11","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","volume":"56","author":"AA Shanab","year":"2011","unstructured":"Shanab AA, Scully P, Crosbie O, Buckley M, O\u2019Mahony L, Shanahan F, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011;56(5):1524\u201334.","journal-title":"Dig Dis Sci"},{"issue":"0","key":"960_CR12","first-page":"1","volume":"0","author":"R Rafiei","year":"2017","unstructured":"Rafiei R, Bemanian M, Rafiei F, Bahrami M, Fooladi L, Ebrahimi G, et al. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth. Rom J Intern Med. 2017;0(0):1\u201312.","journal-title":"Rom J Intern Med"},{"issue":"1","key":"960_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jgh.13058","volume":"31","author":"S Kapil","year":"2016","unstructured":"Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, et al. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2016;31(1):213\u201321.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"960_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","volume":"10","author":"GC Farrell","year":"2013","unstructured":"Farrell GC, Wong VW-S, Chitturi S. NAFLD in Asia\u2014as common and important as in the west. Nat Rev Gastroenterol Hepatol. 2013;10(5):307\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"11","key":"960_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"960_CR16","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"G Marchesini","year":"2016","unstructured":"Marchesini G, Day CP, Dufour J-F, Canbay A, Nobili V, Ratziu V, et al. EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402.","journal-title":"J Hepatol"},{"issue":"4","key":"960_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","volume":"18","author":"JM Sabat\u00e9","year":"2008","unstructured":"Sabat\u00e9 JM, Jou\u00ebt P, Harnois F, Mechler C, Msika S, Grossin M, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18(4):371\u20137.","journal-title":"Obes Surg"},{"issue":"1","key":"960_CR18","first-page":"354","volume":"49","author":"SOUZAM Rodrigues de Ara\u00fajo","year":"2012","unstructured":"Rodrigues de Ara\u00fajo SOUZAM. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol Universidade Federal da Para\u00edba. 2012;49(1):354\u201358036.","journal-title":"Arq Gastroenterol Universidade Federal da Para\u00edba"},{"issue":"5","key":"960_CR19","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5(5):1544\u201360.","journal-title":"Nutrients."},{"issue":"4","key":"960_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1469-0691.12172","volume":"19","author":"M Million","year":"2013","unstructured":"Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect. 2013;19(4):305\u201313.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"960_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4291\/wjgp.v6.i4.110","volume":"6","author":"CK Chakraborti","year":"2015","unstructured":"Chakraborti CK. New-found link between microbiota and obesity. World J Gastrointest Pathophysiol. 2015;6(4):110\u20139.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"3","key":"960_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","volume":"17","author":"UC Ghoshal","year":"2011","unstructured":"Ghoshal UC. How to interpret hydrogen breath test. J Neurogastroenterol Motil. 2011;17(3):312\u20137.","journal-title":"J Neurogastroenterol Motil"},{"key":"960_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","volume":"18","author":"JM Sabate","year":"2008","unstructured":"Sabate JM, Jouet P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371\u20137.","journal-title":"Obes Surg"},{"key":"960_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/gastro\/got007","volume":"1","author":"GLH Wong","year":"2013","unstructured":"Wong GLH. Update of liver fibrosis and steatosis with transient elastography (Fibroscasn). Gastroenterol Rep. 2013;1:19\u201326.","journal-title":"Gastroenterol Rep"},{"issue":"6","key":"960_CR25","doi-asserted-by":"publisher","first-page":"e0157358","DOI":"10.1371\/journal.pone.0157358","volume":"11","author":"HW Lee","year":"2016","unstructured":"Lee HW, Park SY, Kim SU, Jang JY, Park H, Kim JK, et al. Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease. PLoS One. 2016;11(6):e0157358. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0157358\n                    \n                  .","journal-title":"PLoS One"},{"issue":"4","key":"960_CR26","first-page":"242","volume":"7","author":"SA Hashemi","year":"2016","unstructured":"Hashemi SA, Alavian SM, Fesharaki MG. Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Caspian J Intern Med. 2016;7(4):242\u201352.","journal-title":"Caspian J Intern Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-0960-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:09:53Z","timestamp":1584576593000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-0960-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-0960-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This study has been approved by IRB\/Institutional Review Board (Medical Faculty Universitas Indonesia Ethical Committee) no. 899\/UN2.F1\/ETIK\/2017.Written Informed consent was obtained from all the study subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"43"}}